The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension

Movement Disorders

Volumn 26, Issue 11, 2011, Pages 1985-1992

  Pavy Le Traon, Anne ^a,b   Amarenco, Gerard ^c   Duerr, Susanne ^d   Kaufmann, Horacio ^e   Lahrmann, Heinz ^f   Shaftman, Stephanie R ^g   Tison, François ^a,b,h   Wenning, Gregor K ^d   Goetz, Christopher G ⁱ   Poewe, Werner ^d   Sampaio, Cristina ^j   Schrag, Anette ^k   Stebbins, Glenn T ⁱ   Rascol, Olivier ^a,b,l  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c HÔPITAL ROTHSCHILD   (France)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e NEW YORK UNIVERSITY   (United States)

^f KAISER FRANZ JOSEF HOSPITAL   (Austria)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ RUSH MEDICAL COLLEGE   (United States)

^j Lisbon School of Medicine   (Portugal)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l UNIVERSITÉ PAUL SABATIER   (France)

more..

Author keywords

Autonomic failure; Clinimetrics; Orthostatic hypotension; Orthostatic symptoms; Parkinson's disease; Rating scales

Indexed keywords

AUTONOMIC DYSFUNCTION IN PARKINSON DISEASE QUESTIONNAIRE; AUTONOMIC NEUROPATHY; AUTONOMIC SCALE FOR OUTCOME IN PARKINSON DISEASE; BLOOD PRESSURE MONITORING; BLURRED VISION; COMPOSITE AUTONOMIC SCORING SCALE; COMPOSITE AUTONOMIC SYMPTOM SCALE; DIZZINESS; DYSAUTONOMIA; FAINTNESS; FREIBURG QUESTIONNAIRE; HEART RATE; HOBSON ET AL SCALE; HUMAN; NON MOTOR SYMPTOM QUESTIONNAIRE; NON MOTOR SYMPTOM SCALE; ORTHOSTATIC BLOOD PRESSURE; ORTHOSTATIC GRADING SCALE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; SYNCOPE; UNIFIED MULTIPLE SYSTEM ATROPHY RATING SCALE; UNIFIED PARKINSON DISEASE RATING SCALE; WEAKNESS;

ADVISORY COMMITTEES; HUMANS; HYPOTENSION, ORTHOSTATIC; PARKINSON DISEASE; PUBMED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 80052965978     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23742     Document Type: Review

References (46)

1. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470.
2. Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 1996; 6: 125-126.
3. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res 2008; 18(Suppl 1): 8-13.
4. Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 2006; 114: 630-636.
5. Verwoert GC, Mattace-Raso FU, Hofman A, et al. Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study. J Am Geriatr Soc 2008; 56: 1816-1820.
6. Senard JM, Raï S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, Montastruc JL. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63: 584-589.
7. Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2003; 2: 669-676. Review. Erratum in: Lancet Neurol. 2004;3:68.
8. Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1470-1471.
9. Pathak A, Senard JM. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management. Expert Rev Cardiovasc Ther 2004; 2: 393-403.
10. Pathak A, Senard JM. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev Neurother 2006; 6: 1173-1180.
11. Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol 2000; 57: 1461-1463.
12. Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL, Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging 2001; 18: 495-505.
13. Goldstein DS, Eldadah BA, Holmes C, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 2005; 46: 1333-1339.
14. Fujishiro H, Frigerio R, Burnett M, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 2008; 23: 1085-1092.
15. Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 1998; 29: 104-111.
16. Evatt ML, Chaudhuri KR, Chou KL, et al. Dysautonomia Rating Scales in Parkinson's Disease: Sialorrhea, Dysphagia, and Constipation. Critique and recommendations to Movement Disorders Task Force on Rating Scales for Parkinson's disease. Mov Disord 2009; 24: 635-646.
17. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006; 13: 930-936.
18. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
19. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397.
20. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004; 19: 1306-1312.
21. Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, Low PA. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999; 52: 523-528.
22. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-923.
23. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-1629.
24. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. Results from an international pilot study. Mov Disord 2007; 22: 1901-1911.
25. Goetz CG, Tilley BC, Shaftman SR, et al, for the Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170.
26. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 2005; 15: 76-82.
27. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002; 8: 277-284.
28. Hobson P, Islam W, Roberts S, Adhiyman V, Meara J. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. Parkinsonism Relat Disord 2003; 10: 67-71.
29. Schrezenmaier C, Gehrking JA, Hines SM, Low PA, Benrud-Larson LM, Sandroni P. Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. Mayo Clin Proc 2005; 80: 330-334.
30. Mathias CJ, Senard JM, Braune S, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 235-242.
31. Mathias CJ. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auton Res 2008; 18(Suppl 1): 25-29.
32. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA, Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997; 277: 1046-1051.
33. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51: 120-124.
34. Wenning GK, Tison F, Seppi K, et al. Multiple System Atrophy Study Group.Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004; 19: 1391-1402.
35. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993; 68: 748-752.
36. Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995; 70: 617-622.
37. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007; 69: 333-341.
38. Papapetropoulos S, Argyriou AA, Chroni E. No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease. Mov Disord 2006; 21: 430-431.
39. Idiaquez J, Benarroch EE, Rosales H, Milla P, Ríos L. Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res 2007; 17: 93-98.
40. Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio Longitudinal de Pacients con Enfermedad da Parkinson Group. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol 2010; 17: 194-201.
41. Schoffer KL, Henderson RD, O'Maley K, O'sullivan JD. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Mov Disord 2007; 22: 1543-1549.
42. Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DE. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 2007; 100: 519-526.
43. Cai FZ, Lester S, Lu T, et al. Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study. Arthritis Res Ther 2008; 10: 31.
44. Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson's disease. Eur J Neurol 2008; 15(Suppl 2): 2-7.
45. Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 2008; 255(Suppl 5): 33-38.
46. Zibetti M, Torre E, Cinquepalmi A, et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007; 58: 218-223.